Scientists probe gene activity in rare swelling disorder
NCT ID NCT04032002
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at gene activity in immune cells from 30 people with hereditary angioedema and healthy volunteers. The goal was to see if certain receptors on monocytes are linked to inflammation and blood vessel problems. No treatment was given; the study was purely observational to learn more about the disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Nov 2020
- Finished
-
May 2021
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria (patients): * Patient with inherited bradykinic angioedema due to quantitative or qualitative C1-inhibitor deficiencies, regardless of the frequency or severity of seizures and regardless of their background treatment, with the following diagnostic criteria: * C1-inhibitor rate \<50% of normal * Repeated episodes characteristic of bradykinic angioedema * Hereditary nature of the disease. * Person who read and understood the newsletter and signed the consent form * Person affiliated with a social security scheme * Effective contraception in women of childbearing age (negative pregnancy test). For postmenopausal women, a confirmatory diagnosis should be obtained (amenorrhea for at least 12 months before the inclusion visit). Inclusion Criteria (volunteers): * Person affiliated with a social security scheme * Person who read and understood the newsletter and signed the consent form * Effective contraception in women of childbearing age (negative pregnancy test). For postmenopausal women, a confirmation diagnosis should be obtained (amenorrhea for at least 12 months before the inclusion visit) Exclusion Criteria (patients): * Angioedema crisis less than 1 month old * Chronic inflammatory disease such as rheumatoid arthritis or Crohn's disease. * Acute infection in progress, with or without anti-infectious treatment * Contraindication to the use of trinitrin: * Hypersensitivity to nitrates or to any of the excipients * shock, severe hypotension, * obstructive cardiomyopathy, * inferior court inferior myocardial infarction with right ventricular extension, except in case of evidence of left ventricular failure, * intracranial hypertension, * patient treated with sildenafil * Pregnant or parturient or breastfeeding woman or lack of proven contraception * Person deprived of liberty by an administrative or judicial decision or person placed under the protection of justice / sub-tutorship or curatorship * Patient participating or having participated in another therapeutic trial within one week. Exclusion Criteria (volunteers) * Chronic inflammatory disease such as rheumatoid arthritis or Crohn's disease. * Acute infection in progress, with or without anti-infectious treatment * Contraindication to the use of trinitrin: * Hypersensitivity to nitrates or to any of the excipients * shock, severe hypotension, * obstructive cardiomyopathy, * inferior court inferior myocardial infarction with right ventricular extension, except in case of evidence of left ventricular failure, * intracranial hypertension, * patient treated with sildenafil * Pregnant or parturient or breastfeeding woman or lack of proven contraception * Person deprived of liberty by an administrative or judicial decision or person placed under the protection of justice / sub-tutorship or curatorship * Person participating or having participated in another therapeutic trial within one week.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hereditary angioedema due to C1-inhibitor deficiency are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
DRCI
Rouen, 76000, France